Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades T2 Biosystems to Neutral

BTIG Downgrades T2 Biosystems to Neutral

BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

byBenzinga Newsdesk

July 7, 2022

1 minute read

BTIG analyst Mark Massaro downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

Movers
News

What’s Driving The Action In Arista Networks Stock?

By Adam Eckert

August 1, 9:50 AM

Arista Networks Inc (NYSE: ANET) shares are trading higher Tuesday after the networking equipment company reported better-than-expected financial results.

ANET

Here’s How Much $100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today

By Benzinga Insights

October 24, 12:33 PM

CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 13.48% on an annualized basis producing an average annual return of 21.37%. Currently, CRISPR Therapeutics has a market capitalization of $3.89 billion.

CRSP